Evidence map›Paper›PMID 28685320›Full record

ArticleJournal of digital imaging2018

Can Laws Be a Potential PET Image Texture Analysis Approach for Evaluation of Tumor Heterogeneity and Histopathological Characteristics in NSCLC?

Seyhan Karacavus, Bülent Yılmaz, Arzu Tasdemir, Ömer Kayaaltı, Eser Kaya, Semra İçer, Oguzhan Ayyıldız

Open access · bronzeAbstract read
In one paragraph

Article in Journal of digital imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Development and Validation of aFrontiers in oncology · 2021
    Article
  8. A Role for FDG PET Radiomics in Personalized Medicine?Seminars in nuclear medicine · 2020
    Review
  9. Article
  10. What can artificial intelligence teach us about the molecular mechanisms underlying disease?European journal of nuclear medicine and molecular imaging · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Seyhan KaracavusDepartment of Nuclear Medicine, Saglık Bilimleri University, Kayseri Training and Research Hospital, 38010, Kayseri, Turkey. seyhan.karacavus@sbu.edu.tr.
Bülent YılmazDepartment of Electrical and Electronics Engineering, Abdullah Gül University, Engineering Faculty, Kayseri, Turkey.
Arzu TasdemirDepartment of Pathology, Saglik Bilimleri University, Kayseri Training and Research Hospital, Kayseri, Turkey.
Ömer KayaaltıDepartment of Computer Technologies, Erciyes University, Develi Hüseyin Şahin Vocational College, Kayseri, Turkey.
Eser KayaDepartment of Nuclear Medicine, Acibadem University, School of Medicine, İstanbul, Turkey.
Semra İçerDepartment of Biomedical Engineering, Erciyes University, Engineering Faculty, Kayseri, Turkey.
Oguzhan AyyıldızDepartment of Electrical and Electronics Engineering, Abdullah Gül University, Engineering Faculty, Kayseri, Turkey.
Abdullah Gül University · TRErciyes University · TRAcıbadem University · TRSağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the association between the textural features obtained from

Indexed as

Carcinoma, Non-Small-Cell LungFemaleFluorodeoxyglucose F18HumansImage Interpretation, Computer-AssistedLungLung NeoplasmsMaleMiddle AgedPositron-Emission TomographyRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18RadiopharmaceuticalsKi-67PETTexture analysisTumor heterogeneityTumor histopathological characteristics

Identifiers

PMID28685320
PMCPMC5873476
OpenAlexW2724191697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.